Target intelligence / Profile preview

Endoluminal plaque modification via mechanical micro-serration

Molecular classification
Other (not a molecule, but a therapeutic mechanical technique)
01

Overview

Endoluminal plaque modification via mechanical micro-serration refers to a class of procedural or device-based techniques used during endovascular interventions to alter the structure and compliance of vascular plaques—particularly heavily calcified or fibrotic lesions—by creating controlled, focal disruptions or \"micro-serrations\" in the plaque from within the vessel lumen[1][4][6]. Common devices include scoring and cutting balloons, which create linear incisions or disruptions in the plaque, and specialized atherectomy systems designed to fracture or ablate calcified components[1][3][4][7]. The goal is to facilitate subsequent balloon dilation, stent delivery, or drug delivery, and to reduce the risks of suboptimal stent expansion and related complications[1][2][4][9][10]. This is a procedural strategy, not a biological or molecular target.\n\nIf a specific molecular or receptor target is needed, clarification or correction is required, as no recognized canonical molecule fits the description given.

Other names
Plaque modificationplaque micro-serrationvessel preparationscoring balloon angioplastycutting balloon angioplastymechanical plaque scoringendoluminal serration
02

Mechanism of action

Mechanical disruption (scoring or fracturing plaque, including calcium, from within the artery using specialized balloons, scoring systems, or atherectomy devices)\nEnhancement of arterial compliance and luminal gain to allow better expansion of stents or delivery of other therapies

03

Biological functions

Vascular lesion modificationFacilitation of stent delivery/expansionMechanical disruption of atherosclerotic plaque
04

Disease associations

Cardiovascular disease (especially coronary artery disease, peripheral artery disease, carotid artery stenosis)
05

Safety considerations

Vessel dissectionPerforationEmbolization or no-reflow phenomenon (downstream emboli from disrupted plaque)Restenosis (less common with improved techniques and adjunctive drug use)
06

Interacting drugs

Not directly applicable, but commonly used in combination with drug-eluting stents, antiplatelet agents, and sometimes drug-coated balloons
07

Biomarkers

Not applicable; patient and lesion selection is based on imaging (e.g., angiography, intravascular ultrasound, optical coherence tomography), not molecular biomarkers

Beyond the preview

Go deeper on Endoluminal plaque modification via mechanical micro-serration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoluminal plaque modification via mechanical micro-serration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call